146 related articles for article (PubMed ID: 11294073)
21. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
Yang P; Hsu HY; Chiou SS; Chao MC
Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
[TBL] [Abstract][Full Text] [Related]
22. [Attention deficit disorder in childhood].
Van Bogaert P
Rev Med Brux; 2009 Sep; 30(4):239-43. PubMed ID: 19899369
[TBL] [Abstract][Full Text] [Related]
23. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.
Pelham WE; Burrows-Maclean L; Gnagy EM; Fabiano GA; Coles EK; Tresco KE; Chacko A; Wymbs BT; Wienke AL; Walker KS; Hoffman MT
Exp Clin Psychopharmacol; 2005 May; 13(2):111-26. PubMed ID: 15943544
[TBL] [Abstract][Full Text] [Related]
24. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
25. Stimulant effects in attention deficit hyperactivity disorder: theoretical and empirical issues.
Denney CB
J Clin Child Psychol; 2001 Mar; 30(1):98-109. PubMed ID: 11294083
[TBL] [Abstract][Full Text] [Related]
26. Methylphenidate and behavior modification in children with ADHD and comorbid ODD or CD: main and incremental effects across settings.
Kolko DJ; Bukstein OG; Barron J
J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):578-86. PubMed ID: 10230190
[TBL] [Abstract][Full Text] [Related]
27. Co-morbidity and treatment of attention deficit hyperactivity disorder in Saudi Arabia.
Al-Haidar FA
East Mediterr Health J; 2003; 9(5-6):988-95. PubMed ID: 16450529
[TBL] [Abstract][Full Text] [Related]
28. Controversies in ADHD. Fundamental questions being answered slowly, but scientifically.
Flick GL
Adv Nurse Pract; 2002 Feb; 10(2):34-6, 39-43. PubMed ID: 12400297
[No Abstract] [Full Text] [Related]
29. Attention-deficit/hyperactivity disorder.
Shaywitz BA; Fletcher JM; Shaywitz SE
Adv Pediatr; 1997; 44():331-67. PubMed ID: 9265975
[TBL] [Abstract][Full Text] [Related]
30. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
[TBL] [Abstract][Full Text] [Related]
31. Effects of methylphenidate and behavior modification on the social and academic behavior of children with disruptive behavior disorders: the moderating role of callous/unemotional traits.
Waschbusch DA; Carrey NJ; Willoughby MT; King S; Andrade BF
J Clin Child Adolesc Psychol; 2007; 36(4):629-44. PubMed ID: 18088220
[TBL] [Abstract][Full Text] [Related]
32. [Long-term courses in children with attention deficit hyperactivity disorder (ADHD)].
Huss M
MMW Fortschr Med; 2004 Mar; 146(12):36-7, 39. PubMed ID: 15357502
[TBL] [Abstract][Full Text] [Related]
33. Integrated pharmacologic treatment of attention-deficit hyperactivity disorder (ADHD).
Horst RO; Hendren RL
Essent Psychopharmacol; 2005; 6(5):250-61. PubMed ID: 16222910
[TBL] [Abstract][Full Text] [Related]
34. Attention-deficit hyperactivity disorder.
Calis KA; Grothe DR; Elia J
Clin Pharm; 1990 Aug; 9(8):632-42. PubMed ID: 1974836
[TBL] [Abstract][Full Text] [Related]
35. Pharmacotherapy of attention-deficit/hyperactivity disorder in adults.
Wender PH
J Clin Psychiatry; 1998; 59 Suppl 7():76-9. PubMed ID: 9680056
[TBL] [Abstract][Full Text] [Related]
36. [Attention deficit hyperactivity disorder].
Banaschewski T; Konrad K; Rothenberger A; Hebebrand J
Z Kinder Jugendpsychiatr Psychother; 2009 Jul; 37(4):250-65. PubMed ID: 20306781
[No Abstract] [Full Text] [Related]
37. The acceptability of interventions for attention-deficit hyperactivity disorder among elementary and middle school teachers.
Power TJ; Hess LE; Bennett DS
J Dev Behav Pediatr; 1995 Aug; 16(4):238-43. PubMed ID: 7593658
[TBL] [Abstract][Full Text] [Related]
38. Effects of methylphenidate on subtypes of attention-deficit/hyperactivity disorder.
Gorman EB; Klorman R; Thatcher JE; Borgstedt AD
J Am Acad Child Adolesc Psychiatry; 2006 Jul; 45(7):808-16. PubMed ID: 16832317
[TBL] [Abstract][Full Text] [Related]
39. Psychosocial treatments for preschool-aged children with Attention-Deficit Hyperactivity Disorder.
Laforett DR; Murray DW; Kollins SH
Dev Disabil Res Rev; 2008; 14(4):300-10. PubMed ID: 19072758
[TBL] [Abstract][Full Text] [Related]
40. Pharmacotherapy of adult ADHD.
Dodson WW
J Clin Psychol; 2005 May; 61(5):589-606. PubMed ID: 15723384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]